0001567619-22-007387.txt : 20220323 0001567619-22-007387.hdr.sgml : 20220323 20220323163039 ACCESSION NUMBER: 0001567619-22-007387 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220323 DATE AS OF CHANGE: 20220323 EFFECTIVENESS DATE: 20220323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-438648 FILM NUMBER: 22763560 BUSINESS ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ALROY INDUSTRIES INC DATE OF NAME CHANGE: 19850411 D 1 primary_doc.xml X0708 D LIVE 0000748592 Brooklyn ImmunoTherapeutics, Inc. 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY NEW YORK 11220 (212) 582-1199 DELAWARE Alroy Industries, Inc. NTN Buzztime, Inc. NTN Communications Inc. NTN BUZZTIME INC NTN COMMUNICATIONS INC ALROY INDUSTRIES INC Corporation true Howard J. Federoff Brooklyn ImmunoTherapeutics, Inc. 140 58th Street, Building A, Suite 2100 Brooklyn NY NEW YORK 11220 Executive Officer Director Chief Executive Officer and President Erich Mohr Brooklyn ImmunoTherapeutics, Inc. 140 58th Street, Building A, Suite 2100 Brooklyn NY NEW YORK 11220 Director Heather B. Redman Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 New York NY NEW YORK 11220 Director Erin S. Enright Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 Brooklyn NY NEW YORK 11220 Director Dennis Langer Brooklyn ImmunoTherapeutics, Inc. 140 58th Street, Building A, Suite 2100 Brooklyn NY NEW YORK 11220 Director Jay Sial Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 New York NY NEW YORK 11220 Executive Officer Chief Administration Officer Sandra Gurrola Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 Brooklyn NY NEW YORK 11220 Executive Officer Vice President of Finance Kevin D'Amour Brooklyn ImmunoTherapeutics, Inc. 140 58th Street, Building A, Suite 2100 Brooklyn NY NEW YORK 11220 Executive Officer Chief Scientific Officer Roger Sidhu Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 New York NY NEW YORK 11220 Executive Officer Chief Medical Officer Charles Cherington Brooklyn ImmunoTherapeutics, Inc. 509 Madison Avenue, Suite 804 New York NY NEW YORK 11220 Director Biotechnology Decline to Disclose 06b false 2022-03-09 true true true Units consisting of (i) one share of common stock and (ii) one warrant to purchase one share common stock ("common warrants") false 0 Cantor Fitzgerald & Co. 134 None None 499 Park Avenue New York NY NEW YORK 10022 NY NEW YORK false Maxim Group LLC 120708 None None 300 Park Avenue New York NY NEW YORK 10022 NY NEW YORK false 12000000 12000000 0 false 1 900000 0 0 false Brooklyn ImmunoTherapeutics, Inc. /s/ Howard J. Federoff Howard J. Federoff Chief Executive Officer and President 2022-03-23